Thyroid-blocking activity of chlorpropamide in a diabetic patient with hyperthyroidism.

J. Tsou,M. Kotler,R. Lavine
DOI: https://doi.org/10.1001/ARCHINTE.1981.00340050136035
1981-04-01
Archives of Internal Medicine
Abstract:To the Editor. —The oral hypoglycemic agents, the sulfonylurea compounds, are used by many physicians in the treatment of patients with insulinindependent diabetes mellitus. In addition to the well-known hypoglycemic actions of the sulfonylurea compounds, they also exert a less-recognized antithyroid activity similar to propylthiouracil. 1-3 This antithyroid activity of the sulfonylurea compounds is much weaker in comparison to propylthiouracil, and, in the usual therapeutic range, patients receiving sulfonylurea compounds do not manifest a hypothyroid state. 2,4 However, Hunton et al 5 have found a high incidence of hypothyroidism in their diabetic population receiving sulfonylurea compounds. Little is known about the antithyroid action of sulfonylurea compounds in diabetic patients with hyperthyroidism. Brown and Solomon 6 reported that carbutamide had no effect on thyroid function in two patients with hyperthyroidism. A patient with diabetes mellitus and hyperthyroidism had normal thyroid study results induced by chlorpropamide. Report of a Case.
What problem does this paper attempt to address?